Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: The Alzheimer’s disease drug development landscape

Fig. 1

AD drugs in development, preclinical vs clinical. The number of drugs per target class in preclinical development is shown as a percentage of all drugs in preclinical development, and the number of drugs per target class in clinical development is shown as a percentage of all drugs in clinical development

Back to article page